Effect of BIA 5 1058 on Cardiac Repolarization

NCT03489005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease
Pulmonary Arterial Hypertension
Heart Failure

Interventions

DRUG: BIA 5-1058
DRUG: Placebo Oral Tablet
DRUG: Moxifloxacin 400 mg

Sponsor

Bial - Portela C S.A.

Collaborators

[object Object]